Related references
Note: Only part of the references are listed.Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
David A. Reardon et al.
JAMA ONCOLOGY (2020)
Re-irradiation of recurrent glioblastoma using helical TomoTherapy with simultaneous integrated boost: preliminary considerations of treatment efficacy
Donatella Arpa et al.
SCIENTIFIC REPORTS (2020)
Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report
C. Tsien et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO)
Pierina Navarria et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival
Christopher H. Chapman et al.
NEURO-ONCOLOGY PRACTICE (2019)
Appraisal of re-irradiation for the recurrent glioblastoma in the era of MGMT promotor methylation
Il Han Kim
RADIATION ONCOLOGY JOURNAL (2019)
Re-irradiation for recurrent high-grade gliomas: a systematic review and analysis of treatment technique with respect to survival and risk of radionecrosis
Mihir Shanker et al.
NEURO-ONCOLOGY PRACTICE (2019)
Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)
Stephanie E. Combs et al.
CANCER MEDICINE (2018)
Hyperbaric oxygen therapy as adjunctive strategy in treatment of glioblastoma multiforme
Lei Huang et al.
MEDICAL GAS RESEARCH (2018)
Radiotherapy using IMRT boosts after hyperbaric oxygen therapy with chemotherapy for glioblastoma
Katsuya Yahara et al.
JOURNAL OF RADIATION RESEARCH (2017)
Therapeutic options in recurrent glioblastoma-An update
Katharina Seystahl et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
The impact of hypoxia and its modification of the outcome of radiotherapy
Michael R. Horsman et al.
JOURNAL OF RADIATION RESEARCH (2016)
Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours
Katarzyna Stepien et al.
MEDICAL ONCOLOGY (2016)
Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge
Pierina Navarria et al.
CANCER RESEARCH AND TREATMENT (2016)
Hyperbaric oxygen therapy for late radiation tissue injury
Michael H. Bennett et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Radiotherapy after hyperbaric oxygenation in malignant gliomas
Jun-rui Chen et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas
Giuseppe Minniti et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Hypofractionated stereotactic reirradiation for recurrent glioblastoma
Gozde Yazici et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
Walter Taal et al.
LANCET ONCOLOGY (2014)
Old but new methods in radiation oncology: hyperbaric oxygen therapy
Kazuhiko Ogawa et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2013)
Patterns of Failure After Concurrent Bevacizumab and Hypofractionated Stereotactic Radiation Therapy for Recurrent High-Grade Glioma
Lauren Q. Shapiro et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas
Giuseppe Minniti et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
PHASE II TRIAL OF RADIOTHERAPY AFTER HYPERBARIC OXYGENATION WITH MULTIAGENT CHEMOTHERAPY (PROCARBAZINE, NIMUSTINE, AND VINCRISTINE) FOR HIGH-GRADE GLIOMAS: LONG-TERM RESULTS
Kazuhiko Ogawa et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Hyperbaric oxygen therapy and cancer-a review
Ingrid Moen et al.
TARGETED ONCOLOGY (2012)
Hyperbaric oxygen therapy for late radiation tissue injury
Michael H. Bennett et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Angiogenesis and invasion in glioma
Manabu Onishi et al.
BRAIN TUMOR PATHOLOGY (2011)
Treatment of recurrent high grade gliomas with hypofractionated stereotactic image-guided helical tomotherapy
Brian Kim et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2011)
Therapeutic options for recurrent malignant glioma
Maximilian Niyazi et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - A systematic review and meta-analysis
Jens Overgaard
RADIOTHERAPY AND ONCOLOGY (2011)
Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells
Hiromichi Nakabayashi et al.
BMC CANCER (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide
Giuseppe Minniti et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target
Randy L. Jensen
JOURNAL OF NEURO-ONCOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Biology of Angiogenesis and Invasion in Glioma
Matthew C. Tate et al.
NEUROTHERAPEUTICS (2009)
Hypofractionated Stereotactic Reirradiation of Recurrent Glioblastomas
Emmanouil Fokas et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2009)
Expression of hypoxia inducible factor-1α in tumors of patients with glioblastoma multiforme and transitional meningioma
Mehmet Yasar Kaynar et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Inhibition of angiogenesis and invasion in malignant gliomas
Andrew Chi et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2007)
Iatrogenic immunosuppression in patients with newly diagnosed high-grade gliomas
S. A. Grossman et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials
Kathryn A. Carson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas
Kiyotaka Kohshi et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma
Antje Ernst-Stecken et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
The interactions of polarographic measurements of oxygen tension and histological grade in human glioma
Brian E. Lally et al.
CANCER JOURNAL (2006)
Hypofractionated stereotactic re-irradiation:: Treatment option in recurrent malignant glioma -: art. no. 55
D Vordermark et al.
BMC CANCER (2005)
Hyperbaric oxygen: its uses, mechanisms of action and outcomes
AL Gill et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2004)
A phase II study of radiotherapy after hyperbaric oxygenation combined with interferon-beta and nimustine hydrochloride to treat supratentorial malignant gliomas
T Beppu et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Change of oxygen pressure in glioblastoma tissue under various conditions
T Beppu et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
Radiotherapy after hyperbaric oxygenation improves radioresponse in experimental tumor models
N Kunugita et al.
CANCER LETTERS (2001)
Share Paper
